EpiVax takes great pride in providing industry leading and thought provoking content.

Here you may find information on upcoming webinars such as registration and speaker info as well as links to pre-recorded webinars that have passed.

Please reach out to info@epivax.com should you encounter issues with any link.

  • Are we ready for the Immunology Revolution?

    Posted on December 31, 2015 by Steven Vessella
      EpiVax  hosted an exciting JP Morgan Healthcare Conference Event: a panel discussion by expert alumni and friends of the University of Chicago, on new immune therapies (checkpoint inhibitors and personalized cancer vaccines). This event featured a panel with: Moderator: Alexander Johns (College 83, Booth ’87) and Panelists: Anne De Groot (Pritzker ’83, EpiVax), of Robert Ang, (Neon Therapeutics), ...
    Read more
  • EpiVax at the EpiCenter of RI Commerce

    Posted on November 18, 2015 by Steven Vessella
    On Wednesday November 18th, EpiVax CIO/COO Bill Martin welcomed Rhode Island Governor Gina Raimondo, Secretary of Commerce Stefan Pryor and Providence Mayo Jorge Elorza to EpiVax headquaters for a press conference to announce the latest Innovation Initiatives for small businesses in the state. The event was live tweeted @EpiVax_BD. Governor Gina Raimondo is focused on enhancing business growth ...
    Read more
  • Yale & CURE BioHaven presents ‘Vaccine Pipelines 2015’

    Posted on October 20, 2015 by Steven Vessella
    VACCINES 2015 – Building Pipelines to Serve Unmet Medical Needs And Target Commercial Opportunity Wednesday, October 28 4:00 pm – 6:00 pm Anlyan Center at Yale 300 Cedar Street New Haven, CT 06519 Details and Registration This Yale & CURE BioHaven event assembles experts from 4 companies to trade business stories and share their thinking about how to position and sell vaccines ...
    Read more
  • EpiVax to Present at 52nd IBRCC Meeting

    Posted on October 5, 2015 by Steven Vessella
    EpiVax will present the latest information about Stealth Botox at the upcoming Interagency Botulism Research Coordinating Committee (IBRCC) meeting in Frederick, Maryland. IBRCC is an annual national and international forum for presenting state-of-the-art research on botulinum toxin and the deadly disease it causes, botulism. The fundamental purpose of IBRCC is to provide a mechanism for coordination ...
    Read more
  • 9th Vaccine Renaissance: Last Call for Abstracts

    Posted on September 11, 2015 by Katie Porter
    ONE MORE DAY TO SUBMIT YOUR ABSTRACT! 9th Vaccine Renaissance Conference Providence, RI – November 4-6, 2015 The 9th Annual Vaccine Renaissance Conference planning committee is pleased to invite you to submit an abstract for consideration. This year the focus will be on new methods that will improve vaccine efficacy and safety and on the crucial role ...
    Read more
  • Where in the World is EpiVax?

    Posted on August 11, 2015 by Katie Porter
    Having a hard time keeping up with the EpiVaxer’s?   Click HERE for more information about where we will be in September & October! October 15th → Taipei, Taiwan •Thursday, October 15th: 1st annual Westin Taipei Immunogenicity Seminar (FREE!). Click HERE to register. October 17th-24th → Seoul, Korea •Saturday, October 17th: Computational Vaccinology Workshop (CV5) at 9th Vaccine & ISV Annual ...
    Read more
  • Westin Immunogenicity Seminar comes to Taipei! (Updated)

    Posted on July 21, 2015 by Katie Porter
    EpiVax’s 1st annual Westin Taipei Immunogenicity Seminar is coming to Taiwan! Update: The Westin Taipei Immunogenicity Seminar took place on October 15th and the room was nearly filled to capacity. The inaugural seminar in Taiwan was a great success and our audience was very pleased with the event outcome. We are already thinking about our next event ...
    Read more
  • EpiVax Tokyo Fall visit – Westin Immunogenicity Seminar (Updated)

    Posted on June 25, 2015 by Katie Porter
    Announcing the date for EpiVax’s annual Westin Immunogenicity Seminar. Update: The Westin Tokyo Immunogenicity Seminar took place on September 14th. We are already thinking about our next event in Tokyo which will coincide with the Japanese College of Rheumatology Annual Scientific Meeting in April 2016. Special thanks to our speakers for bringing their exciting work to seminar . Please enjoy commemorative ...
    Read more
  • Westin Immunogenicity Seminar, Daejeon – October 2015

    Posted on June 23, 2015 by Steven Vessella
    The Westin Immunogenicity Seminar Daejeon is scheduled on the 22nd of October. Sign up now to attend! Last year’s speakers included: Dr. Sung-Joo Lee (State of Biotechnology in S. Korea), Head of Research, Sanofi Asia Pacific R&D, Dr. Katy Park (Cancer Vaccines), Korea University College of Medicine, and Dr. Annie De Groot, CEO/CSO, EpiVax and Director and Professor, University of Rhode Island ...
    Read more
  • 5th Computational Vaccinology Workshop (CV5) at ISV

    Posted on June 1, 2015 by Annie De Groot
    We invite you to join us for this year’s iteration of the Computational Vaccinology Workshop @ ISV. Register for this event! Abstract submissions for full-length papers and posters are still being accepted – submit your abstracts now. The 5th Computational Vaccinology Workshop at International Society for Vaccines (CV5 @ ISV) is a satellite workshop to be held Saturday, October 17th ...
    Read more
  • Fearless Science @Bio 2015

    Posted on May 28, 2015 by Steven Vessella
    Fearless Science comes to BIO International Wednesday, June 17th, Philadelphia, PA 7-9:30 pm XIX Restaurant 200 South Broad Street Philadelphia, PA 19102 Annie, Kelsey and Steven will be partnering all day long and… relaxing at night above the Hyatt at The Bellevue at XIX Restaurant! Just a short walk or cab ride from the Pennsylvania Convention Center. We would love ...
    Read more
  • Lyon Seminar: Immunogenicity Determinants and Tolerance

    Posted on May 14, 2015 by Katie Porter
    EpiVax and Platine Pharma Services are co-organizing our first international appointment of industries and academic scientists to exchange knowledge about Immunogenicity Determinants and Tolerance. For the first time in Lyon, France, we would be pleased if you would join us to meet experts and develop networking opportunities on immunogenicity topics. This free, one-day seminar is being ...
    Read more
  • URI Accepting Fellows for NTD Vaccine Design Toolkit and Training Workshop Set for May 2015

    Posted on March 29, 2015 by Anthony Marcello
    PROVIDENCE, R.I. – March 26, 2015 – The University of Rhode Island’s Institute for Immunology and Informatics is currently accepting fellows to participate in a workshop and training course targeting neglected tropical diseases (NTD) and emerging infectious diseases (EID). The workshop will focus on training NTD/EID researchers interested in using new vaccine design tools developed by Principal ...
    Read more
  • Westin Immunogenicity Seminar Seoul – April 2015

    Posted on March 28, 2015 by Annie De Groot
    UPDATE: April 28th, 2015. Here are the slides that EpiVax presented at the seminar: Vaccine Design Using in Silico Tools (6.4MB) Immunogenicity Screening and Epitope Engineering (6.3MB) We had a great time in Seoul and we hope you did also! Thank you for your participation and engagement. If you have any questions please email info@epivax.com for a prompt reply. We hope to ...
    Read more
  • Gordon Research Conference – Tropical Infectious Diseases

    Posted on March 4, 2015 by Katie Porter
    March 8-13 Galveston, Texas EpiVax will be attending the 2015 Gordon Research Conference on “Tropical Infectious Diseases” from March 8th-13th. Dr. Lenny Moise will present “Immunoinformatics: New Platforms for Vaccine Target Discovery”. Participants will have an opportunity to attend an afternoon workshop (March 11 from 2-4pm) at University of Texas Medical Branch to receive hands-on training in ...
    Read more
  • BIO-Europe Spring

    Posted on March 4, 2015 by Katie Porter
    March 9-11 Paris, France Partner with us at BIO-Europe Spring! EpiVax will be returning to this “must attend” event for getting business done in the biotech industry. We will be joining international leaders from biotech, pharma and finance to identify and enter new strategic relationships. Sign up to meet us now through the partnering system or ...
    Read more
  • URI Hosts TRIAD Workshop on Neglected and Emerging Infectious Diseases

    Posted on November 18, 2014 by Katie Porter
    Translational Immunology Research and Accelerated Development program (TRIAD) We would like to invite you to apply to the TRIAD workshop on Neglected and Emerging Infectious Disease Vaccines Design Toolkit & Training. The workshop will be held for two weeks from January 5-16, 2015 at the Institute for Immunology and Informatics (iCubed) at the University of ...
    Read more
  • Antigen Specific Tolerance Induction at Immunogenicity Summit Nov 19 2014

    Posted on November 18, 2014 by Annie De Groot
    Why is antigen-specificity key for biologics?  Annie De Groot, MD, CEO and CSO of EpiVax will be speaking at the CHI Immunogenicity summit on this topic, November 19th at 3 PM. It’s well known that tolerance can be induced by powerful transplant drugs but combining those powerful agents with biologics would not be generally acceptable (certainly not ...
    Read more
  • The Story-Telling-Cloth – Or how we use Textiles as Social Media to improve Vaccine Uptake

    Posted on November 4, 2014 by Annie De Groot
    GAIA Vaccine Foundation’s Story-Telling Cloth receives “Grand Challenges Explorations Grant” Award For West African-Style “Social Media” Cervical Cancer Prevention Campaign Providence, Rhode Island, 04 November 2014. The Bill and Melinda Gates Foundation awarded $100,000 to GAIA Vaccine Foundation to test whether dissemination of a printed cloth that tells the story of HPV, coupled with a media campaign ...
    Read more
  • Senator Whitehouse

    Senator Whitehouse, Homeland Security Headline Vaccine Renaissance Conference

    Posted on October 14, 2014 by Annie De Groot
    Senator Whitehouse (RI) addressed more than 100 experts in the field of vaccine development today at the 8th Vaccine Renaissance, an annual event organized by the University of Rhode Island’s Institute for Immunology and Informatics and supported by EpiVax. He stated that it was tragic that the Sequester achieved what it set out to do – to be a ...
    Read more
  • 8th Vaccine Renaissance October 13-16 2014

    Posted on October 8, 2014 by Annie De Groot
    Vaccine experts to gather in Providence as fight against deadly diseases carries on   Providence, R.I. – October 8, 2014 – As many African countries as well as the United States continue to grapple with the outbreak of Ebola and other deadly diseases, the University of Rhode Island is getting ready to play host to some of ...
    Read more
  • Puesto Party Tonight!

    Posted on June 24, 2014 by Anthony Marcello
    Join us for the EpiVax and Platine BIO 2014 party tonight starting 7 pm at Puesto in San Diego. Food and drinks will be provided by EpiVax and our good friends at Platine Pharma Services. You don’t want to miss this event! If you cannot make it to the Puesto event and would still like to ...
    Read more
  • CV4 Submission Deadline Extended!

    Posted on June 24, 2014 by Anthony Marcello
    We are pleased to announce an extension of the deadline to submit full-length papers to the 4th Computational Vaccinology Workshop. The deadline, originally July 1st will be extended to August 4th.  The deadline for poster abstracts is August 25th. Hopefully this extra time will allow you to polish your submissions to this exciting workshop. For more details ...
    Read more
  • Dr. Leslie Cousens to Speak at CRS Novozymes Workshop

    Posted on June 11, 2014 by Anthony Marcello
    Albumin: The Next Generation Protein Therapeutic Cosponsored by Novozymes Biopharma Inc. About the Workshop Saturday, July 12, 08:45 – 17:00 Organizers: Kenneth Howard, Aarhus University, Denmark, and Daniel Shelly, Novozymes Biopharma US, Inc., U.S.A. Albumin is the most abundant human plasma protein that exhibits prolonged circulatory half-life and a predominant role in extracellular and intracellular transport of nutrients. Exploitation of these ...
    Read more
  • EpiVax at SMi Immunogenicity Conference in London

    Posted on June 10, 2014 by Anthony Marcello
    Dr. Anne De Groot will be a Keynote Speaker at the SMI’s inaugural conference on Immunogenicity, taking place in London on July 14th and 15th. The SMi Conference brochure and agenda can be found here. Here is some information about Dr. De Groot’s Keynote Presentation on  July 14th at 11:00 am: Tregitopes an Immunomodulation Powerhouse: Regulating Immune Responses to ...
    Read more
  • EpiVax at BIO San Diego

    Posted on May 30, 2014 by Anthony Marcello
    EpiVax will be attending this year’s BIO International Convention in San Diego June 23-26. BIO International is the world’s largest biotechnology gathering and we are always looking to learn more about the frontiers of the biotechnology industry. Annie De Groot and Anthony Marcello will be attending and participating in partnering meetings. If you would like to meet for a ...
    Read more
  • 5 New EpiVax Posters at AAPS 2014 in San Diego

    Posted on May 14, 2014 by Anthony Marcello
    EpiVax is attending the 2014 AAPS National Biotechnology Conference, in beautiful San Diego.  We will be presenting 5 new posters (see posters below). Also, come pick up some EpiVax schwag at our table! Brand New EpiVax Posters: Regulating Immune Responses to Biologics: Validation of Screening, Deimmunization and Tolerization Approaches – May 2014 Tolerization as a Rational Design Approach for Reducing the Immunogenicity ...
    Read more
  • EpiVax & Platine BIO 2014 Puesto Party! You’re Invited!

    Posted on May 13, 2014 by Anthony Marcello
    EpiVax and Platine Pharma will be at the BIO international Convention in San Diego June 23-26, 2014. We are hosting a Networking Party at Puesto on Tuesday 24th at 7pm-930pm. If you are reading this, you’re invited. We hope to see you there! Where: Puesto (Puesto Website) When: Tuesday 24th at 7pm-930pm Who: EpiVax, inc., Platine Pharma, and Friends What: Networking party ...
    Read more
  • EpiVax Presenting CHOPPI at 1st HCP Workshop in Dubrovnik, Croatia 2014

    Posted on May 13, 2014 by Anthony Marcello
    EpiVax is pleased to announce our participation with the first HCP Workshop to take place May 15-16, 2014 in Dubrovnik, Croatia. EpiVax will be presenting their approch to assessing the immunogenic potential of host cell proteins using a proprietary in-silico tool, CHOPPI. See slides below. The CHOPPI project is a collaboration between Dartmouth College, EpiVax, Inc. and ...
    Read more
  • EpiVax Immunogenicity Seminar – September 17th 2014 at the Westin Tokyo

    Posted on May 12, 2014 by Anthony Marcello
    EpiVax will be in Tokyo Japan from September 14th-20th, 2014 hosting our semiannual immunogenicity seminar and meeting with collaborators. The Westin Immunogenicity Seminar is scheduled for September 17th, 2014. The purpose of this seminar is to bridge the gap between recent academic research on Tregs, Tregitopes and protein drug development (immunogenicity, deimmunization and tolerance induction). Links PDF Agenda Last year’s event ...
    Read more
  • Participate in the 4th Computational Vaccinology Workshop at ISV

    Posted on May 9, 2014 by Anthony Marcello
    On October 25th EpiVax will be hosting the Computational Vaccinology Workshop at ISV. This marks the 4th year of the Computational Vaccinology Worskhop, previously known as ICoVax, a pre-conference workshop to the 8th International Vaccine and ISV Congress, which will be held October 26-28th, 2014 in Philadelphia, PA. Featuring oral presentations, posters and hands-on software demonstrations, ...
    Read more
  • Hands on iVAX Training at Vaccine Technology V Riviera Maya Mexico

    Posted on April 29, 2014 by Anthony Marcello
    EpiVax is attending and presenting at the “Vaccine Technology V” conference in the Mexican Riviera. June 8-13, 2014 Paradisus Hotel Playa del Carmen, Mexico Conference Website Register Here Click the picture below to download a PDF flyer.   EpiVax will also host a hands-on training workshop. Learn how to use EpiVax’s unique vaccines design software, iVAX. *workshop description coming soon. Learn more about iVAX ...
    Read more
  • EpiVax Attending PEGS Boston

    Posted on April 29, 2014 by Anthony Marcello
    EpiVax will be attending PEGS in Boston May 5-9th, 2014 and presenting 1 poster. Over 1,600 participants will gather in Boston’s vibrant seaport district for open forum discussions and collaboration at CHI’s flagship biologics event “PEGS the essential protein engineering summit”. The continued success of PEGS is driven by the growth in biologics worldwide, the quality ...
    Read more
  • De Groot to speak at ASCLS-CNE event

    Posted on April 24, 2014 by Anthony Marcello
    APRIL 24, 2014 EpiVax CEO/CSO, Dr. Annie De Groot MD, will be one of the featured speakers during next week’s 66th Annual Clinical Laboratory Science Convention. The event is scheduled for April 29 through May 1 at the Rhode Island Convention Center in Providence. Dr. De Groot will speak on Tuesday, April 29 during a workshop on ...
    Read more
  • Immunogenicity and Tolerance Seminar – Amsterdam 2016

    Posted on April 1, 2014 by Steven Vessella
    Platine ​and ​EpiVax are ​co-organizing ​their ​2nd ​seminar on Immunogenicity and Tolerance on October 24th, 2016. Click this link to register This meeting will focus on the determinants of immunogenicity – a key feature of effective vaccines and a key barrier to success in the clinic for protein therapeutics. Conversely, tolerance induction is a key feature of successful protein therapeutics, while ...
    Read more
  • EpiVax at the Coral Gables Symposium, Understanding Immunogenicity 2014

    Posted on March 27, 2014 by Anthony Marcello
    EpiVax’s BDA, Anthony Marcello is attending the Coral Gables Symposium: Understanding Immunogenicity 2014, and will be presenting 3 posters, see below: Antigen-specific tolerance induction by Tregitopes in vivo. In silico High Throughput Pre-clinical Determination of Monoclonal Antibody Immunogenicity Immunogenic Biologics: Validation of Screening, Deimmunization and Tolerization Approaches The 2014 Coral Gables Symposium will focus on an understanding of the ...
    Read more
  • Join us in Nice!

    Posted on March 26, 2014 by Anthony Marcello
    The 9th International Congress on Autoimmunity has kicked off! We are looking forwards to the presentations over the next 5 days, sure to be insightful and innovative. If you haven’t heard EpiVax is hosting Tregitope Nice – a scientific symposium entitled “Tregitopes and Tregs in Autoimmunity” on Saturday, March 29th. Meet us at 10:30 in the ...
    Read more
  • EpiVax Eurotrip Spring 2014

    Posted on February 11, 2014 by Anthony Marcello
    Aah, Europe! EpiVax is taking a Euro trip this spring, but no, we won’t be roughing it in hostels – we’ll be at conferences and meeting with our EU-based partners, working on collaborations that aim to make protein therapeutics safe, vaccines effective and develop innovative solutions to immunogenicity problems. First stop – Amsterdam to meet Phoebe ...
    Read more
  • Partner with us at BIO Europe March 10th-12th in Turin

    Posted on February 11, 2014 by Anthony Marcello
                Looking for an opportunity to meet with Dr. Anne De Groot and learn more about EpiVax? We will be attending the BIO Europe Spring conference in Turin, March 10th through 12th. We are very excited to meet new groups within the vast European biotech circle. If you know EpiVax, you know we work with a ...
    Read more
  • Dr. Lenny Moise to Speak at World Vaccine Congress 2014

    Posted on January 29, 2014 by Anthony Marcello
    Dr. Lenny Moise, Director of Vaccine Research EpiVax, Inc., Providence, RI, United States Talk Title: Immunome-Derived Vaccines: The next wave in vaccine design March 26th, 2014 @ 12:20  Conference Website Here Lenny Moise, PhD is Director of Vaccine Research at EpiVax, Inc. Dr. Moise received his PhD from the Department of Molecular and Cellular Biology and Biochemistry at Brown University ...
    Read more
  • Dr. Anne De Groot Speaking at GTC Bio

    Posted on December 12, 2013 by Anthony Marcello
    Dr. Anne De Groot has been invited to speak at the GTC 2nd Immunogenicity and Immunotoxicity Conference January 30-31st in San Diego, CA. This conference is one of four co-located conferences for the Novel Immunotherapeutics Summit 2014 and focuses on important progress made in the ares of therapeutic protein immunogenicity and immunotoxicity evaluation and mitigation. Learn ...
    Read more
  • Don’t Miss! Free Webinar on Epitope Driven Vaccines by Anne De Groot

    Posted on November 21, 2013 by Anthony Marcello
    Interested in learning more about innovative technologies in vaccine development? Dr. Anne De Groot, CEO/CSO of EpiVax, will be giving a FREE webinar lecture entitled “Designing an epitope-driven vaccine for a “stealth virus” – H7N9 case study“, generously hosted by DNAvaccine.com. Her lecture will explore the principles and applications of epitope-driven vaccines, using H7N9 as a case study.  Join us on December 6th ...
    Read more
  • EpiVax at Biotech Showcase, January 2014

    Posted on November 20, 2013 by Anthony Marcello
    EpiVax is excited to announce that we will be attending the 6th Annual Biotech Showcase in San Francisco, January 13th to 15th. We will be engaging in partnering sessions and will be featuring our own innovative technology platforms, including ISPRI for best in class protein immunogenicity screening, iVAX our web-based gene-to-vaccine design platform, and Tregitope, our novel immunomodulatory molecule. ...
    Read more
  • Annie De Groot to Speak at ASHI on Tregitopes, Tolerance and Transplantation

    Posted on November 18, 2013 by Anthony Marcello
    EpiVax’ very own Dr. Annie De Groot is an invited speaker at the ASHI annual meeting this week. She will be providing a talk on the morning of Tuesday, November 19th,  2013 during the 39th annual meeting of American Society for Histocompatibility and Immunogenetics (ASHI) (http://www.ashi-hla.org/) to be held in Sheraton Chicago Hotel & Towers, ...
    Read more
  • EpiVax Attending Immunogenicity Summit in DC – Presenting 3 Posters!

    Posted on November 4, 2013 by Anthony Marcello
    EpiVax will be attending the upcoming Immunogenicity Summit in DC. EpiVax’ BDA, Anthony Marcello, will be presenting 3 posters (see below) on behalf of the EpiVax science team. Additionally, one of EpiVax’ Tregitope collaborators, Dr. David W. Scott, will be giving an exciting talk about tolerization approaches to FVIII therapy. Posters:  Antigen-specific tolerance induction by Tregitopes in vivo Immunogenic ...
    Read more
  • Tregitope Europe at the 9th International Congress on Autoimmunity in Nice

    Posted on November 1, 2013 by Anthony Marcello
    We are pleased to announce that EpiVax is hosting the “Tregitope Europe” meeting in conjunction with the 9th International Congress on Autoimmunity in Nice, France on March 26th 2014. The meeting will consist of a 120 minute scientific session as part of the main conference dedicated to research and technology for treg based immune modulation. Tregitope Europe continues ...
    Read more
  • Dr. De Groot Presenting CHOPPI in Basel at 6th Workshop on Monoclonal Antibodies

    Posted on September 11, 2013 by Anthony Marcello
    Dr. Annie De Groot is an invited speaker at the 6th Workshop on Monoclonal Antibodies in Basel, Switzerland, on September 12th, 2013. She will presenting information on CHO host cells proteins (HPC’s) and their effects on the immunogenicity of biologics. She will also present information regarding the CHOPPI website, a free online immunogenicity screening tool ...
    Read more
  • The 3rd ISV Pre-conference Computational Vaccinology Workshop (ICoVax 2013)

    Posted on September 10, 2013 by Anthony Marcello
    Introduction: The annual Vaccine & ISV Annual Global Congress, co-organized by the Vaccine journal and the International Society for Vaccines (ISV), is the largest non-commercial conference in the vaccine field and attended by vaccine experts and researchers around the world. The journal Vaccine (http://www.journals.elsevier.com/vaccine/) is the pre-eminent journal for those interested in vaccines and vaccination.  ISV ...
    Read more
  • 4th Immunoinformatics and Computational Immunology Workshop (ICIW)

    Posted on September 6, 2013 by Anthony Marcello
    4th Immunoinformatics and Computational Immunology Workshop EpiVax will be the 4th ICIW this year! We will be presenting posters and extensive iVAX and ISPRI demos. We hope to see you there. EpiVax Accepted Posters (PDF’s linked): A.S. De Groot, P. Bertino, P. Hoffman, M. Carbone, A.G. Siccardi, F. Terry, L.P. Cousens, L. Moise, and W. Martin. Highly Immunogenic ...
    Read more
  • 7th Vaccine Renaissance Conference – Abstracts Due Sept 15

    Posted on August 22, 2013 by Anthony Marcello
    Registration is now open and abstracts are being accpeted, for 7th Annual Vaccine Renaissance Conference Providence, RI Registration is now open for iCubed’s seventh annual Vaccine Renaissance Conference. The conference is slated for October 16-18, 2013 in Providence, Rhode Island. Abstracts are being accepted and the deadline is September 15th – send 250 word abstract to Patrick Lowney ...
    Read more